|
|
Post by straightly on Dec 11, 2017 12:25:26 GMT -5
This thread is for the celebrating of (WAY over) 500 script count!
474 was what Symphony reported. There is already a thread discussing the disparity of these numbers.
What's IMS's new rx and refill split?
I am surprised the muted reactions this number has received so far given that so many of us had been waiting for the 500 breakthrough.
|
|
|
|
Post by goyocafe on Dec 11, 2017 12:30:35 GMT -5
This thread is for the celebrating of (WAY over) 500 script count! 474 was what Symphony reported. There is already a thread discussing the disparity of these numbers. What's IMS's new rx and refill split? I am surprised the muted reactions this number has received so far given that so many of us had been waiting for the 500 breakthrough. When there’s a zero at the end of either number, you won’t be able to get me off the ceiling. |
|
|
|
Post by madog365 on Dec 11, 2017 12:32:51 GMT -5
i'd like to see and compare the week over week growth to symphony
|
|
|
|
Post by dreamboatcruise on Dec 11, 2017 15:02:30 GMT -5
This thread is for the celebrating of (WAY over) 500 script count! 474 was what Symphony reported. There is already a thread discussing the disparity of these numbers. What's IMS's new rx and refill split? I am surprised the muted reactions this number has received so far given that so many of us had been waiting for the 500 breakthrough. The muted response is likely because you are comparing an Apple to an Orange. Unless I'm missing something we don't have IMS data for prior periods so we really have no idea whether this represents a jump in scripts or merely an offset in the number from Symphony estimates that may have existed all along. We roughly know that Symphony $$ numbers multiplied by 0.65 translates to MNKD revenue. If IMS numbers are consistently higher than Symphony it would mean any revenue projection based on them would need higher discount factor. Actual revenue is what matters, not finding some source of data that crosses an arbitrary threshold. |
|
